127 related articles for article (PubMed ID: 1390307)
1. A comparison of CA-549 with CA 15-3 and MCA in patients with metastatic breast cancer.
de Wit R; Hoek FJ; Bakker PJ; Veenhof CH
Ann Oncol; 1992 Apr; 3(4):314-5. PubMed ID: 1390307
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment concentrations of breast carcinoma antigen (CA 15.3) and mucin-like carcinoma-associated antigen in patients with carcinoma of the breast.
Góźdź SS; Kowalska MM; Słuszniak JT; Słuszniak A; Korejba W; Bukowski J; Banasińska E; al-Jazzaf H; Szymendera JJ
Tumour Biol; 1989; 10(2):103-8. PubMed ID: 2734547
[TBL] [Abstract][Full Text] [Related]
3. CA-15.3, TPA and MCA as markers for breast cancer.
Barak M; Steiner M; Finkel B; Abrahamson J; Antal S; Gruener N
Eur J Cancer; 1990; 26(5):577-80. PubMed ID: 2144745
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of a mucin-like carcinoma-associated antigen in monitoring breast cancer patients in comparison with CA 15-3.
Miserez AR; Günes I; Müller-Brand J; Walther E; Fridrich R; Mäcke H
Eur J Cancer; 1991; 27(2):126-31. PubMed ID: 1827273
[TBL] [Abstract][Full Text] [Related]
5. The value of MCA, CA 15-3, CEA and CA-125 for discrimination between metastatic breast cancer and adenocarcinoma of other primary sites.
De Wit R; Hoek FJ; Bakker PJ; Veenhof CH
J Intern Med; 1991 May; 229(5):463-6. PubMed ID: 2040873
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of metastatic breast cancer patients with a mucin-like carcinoma-associated antigen: comparison to CA 15.3 and carcinoembryonic antigen.
Bieglmayer C; Szepesi T; Neunteufel W
Cancer Lett; 1988 Nov; 42(3):199-206. PubMed ID: 2461250
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer.
Rasoul-Rockenschaub S; Zielinski CC; Kubista E; Vavra N; Pospischil E; Staffen A; Czerwenka K; Aiginger P; Spona J
Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1067-72. PubMed ID: 2759162
[TBL] [Abstract][Full Text] [Related]
8. Serial serum MCA measurements in the follow-up of breast cancer patients.
Merimsky O; Inbar M; Hareuveni M; Witenberg B; Wolman Y; Chaitchik S
Eur J Cancer; 1991; 27(11):1440-4. PubMed ID: 1835861
[TBL] [Abstract][Full Text] [Related]
9. Comparison of tumour markers TAG 12 with CA 15-3 and MCA in breast cancer diagnosis.
Eskelinen M; Hippelainen M; Salmela E; Paajanen H; Carlsson L; Jonsson P; Alhava E
Anticancer Res; 1992; 12(1):39-42. PubMed ID: 1567179
[TBL] [Abstract][Full Text] [Related]
10. [The value of tumor markers CA 15-3 and CEA in breast cancer].
Buck I; Lindner C; Böge K; Kitschke HJ
Arch Gynecol Obstet; 1989; 245(1-4):674-7. PubMed ID: 2802753
[TBL] [Abstract][Full Text] [Related]
11. Mucin-like cancer-associated antigen (MCA) compared with CA 15-3 in advanced breast cancer.
Steger GG; Mader R; Derfler K; Moser K; Dittrich C
Klin Wochenschr; 1989 Aug; 67(16):813-7. PubMed ID: 2796251
[TBL] [Abstract][Full Text] [Related]
12. The role of CA 15-3 and MCA monoclonal antibody assays in the detection of primary and recurrent breast cancer.
Pirolo F; Pacini P; Borsotti M; la Morgia R; Mungai R; Cappellini M; Cardona G; Cataliotti L; Marzano S; Neri B
Anticancer Res; 1991; 11(2):729-31. PubMed ID: 2064326
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated antigens in effusions of malignant and benign origin.
Ammon A; Eiffert H; Reil S; Beyer JH; Droese M; Hiddemann W
Clin Investig; 1993 Jun; 71(6):437-44. PubMed ID: 8353402
[TBL] [Abstract][Full Text] [Related]
14. [Sensitivity and specificity of CEA, Ca 15-3 and MCA levels in visceral breast carcinoma metastasis].
Delbrück H; Hagen-Aukamp C; Braun G
Strahlenther Onkol; 1990 Jul; 166(7):457-9. PubMed ID: 2200152
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of mucin-like carcinoma associated antigen (MCA) in breast cancer.
Cooper EH; Forbes MA; Hancock AK; Price JJ; Parker D
Br J Cancer; 1989 May; 59(5):797-800. PubMed ID: 2736216
[TBL] [Abstract][Full Text] [Related]
16. Markers in breast cancer: does CEA add to the detection by CA 15.3?
Delarue JC; Mouriesse H; Dubois F; Friedman S; May-Levin F
Breast Cancer Res Treat; 1988 Jul; 11(3):273-6. PubMed ID: 3167234
[TBL] [Abstract][Full Text] [Related]
17. A preliminary report on the usefulness of monoclonal antibodies to CA 15-3 and MCA in the detection of micrometastases in axillary lymph nodes draining primary breast carcinoma.
Byrne J; Horgan PG; England S; Callaghan J; Given HF
Eur J Cancer; 1992; 28(2-3):658-60. PubMed ID: 1591088
[TBL] [Abstract][Full Text] [Related]
18. Use of mucin like cancer associated antigen (MCA) in the management of breast cancer.
Laurence V; Forbes MA; Cooper EH
Br J Cancer; 1991 Jun; 63(6):1000-4. PubMed ID: 2069833
[TBL] [Abstract][Full Text] [Related]
19. The correlation between the immunohistochemical expression of DF3 antigen and serum CA15-3 in breast cancer patients.
Ohuchi N; Sato S; Akimoto M; Taira Y; Matoba N; Takahashi K; Mori S
Jpn J Surg; 1991 Mar; 21(2):129-37. PubMed ID: 1646903
[TBL] [Abstract][Full Text] [Related]
20. MCA, a monoclonal-antibody-defined breast-tumor-associated antigen and its relation to CA 15.3.
Bieglmayer C; Szepesi T; Neunteufel W; Nowotny C
Tumour Biol; 1989; 10(5):232-42. PubMed ID: 2814232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
